Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

Timothy Larkin v. Thoratec Corp.; St. Jude Medical Inc.; Spyder Merger Corp.;

St. Jude's plan to acquire Thoratec, a leader in heart-failure therapies, at $63.50 a share for $3.4 billion is the product of a flawed process, a class of shareholders claims.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...